Get started
Author

L. R. Kaiser

Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation.
1989 · H S Glazer, L R Kaiser, et al. · Radiology · 149
Prognostic value of FDG PET imaging in malignant pleural mesothelioma.
1999 · F Bénard, D Sterman, et al. · PubMed · 133
Follow-up of non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
2000 · W T Sause, R W Byhardt, et al. · PubMed · 29
Epidemiology of lung cancer.
1997 · J S Friedberg, L R Kaiser · PubMed · 13
Non-aggressive, non-surgical treatment of inoperable non-small cell lung cancer (NSCLC). American College of Radiology. ACR Appropriateness Criteria.
2000 · M V Graham, R W Byhardt, et al. · PubMed · 6
Editorial
1997 · L R Kaiser, S M Albelda · The Annals of Thoracic Surgery · 5
Postoperative radiation therapy in non-small cell lung cancer
1991 · B. Ememi, L. Kaiser, et al. · Lung Cancer · 5
Non-small cell lung cancer, nonsurgical, aggressive therapy. American College of Radiology. ACR Appropriateness Criteria.
2000 · R Komaki, W T Sause, et al. · PubMed · 4
Postoperative radiotherapy in non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
2000 · T H Weisenburger, M V Graham, et al. · PubMed · 4
Two-dimensional echocardiography for diagnosing acute ascending aortic dissection.
1985 · J T Diehl, L R Kaiser, et al. · PubMed · 3
Feasibility of Administering Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] for Targeted Conditioning in Older Patients with Active, Relapsed or Refractory AML without Lead-Lined Rooms: Ongoing Phase III Sierra Trial Experience at 6 Study Sites
2020 · Rajneesh Nath, Bae Chu, et al. · Transplantation and Cellular Therapy · 1
Staging of non-small cell lung carcinoma. American College of Radiology. ACR Appropriateness Criteria.
2000 · B Ko, W T Sause, et al. · PubMed · 1
Threshold-based meningioma delineation in SSR-targeted PET
2021 · A Holzgreve, L Kaiser, et al. · Nuklearmedizin - NuclearMedicine
Risk Stratification with the Aid of 18F-FDG-PET/CT and neural Networks in Head and Neck Cancer Patients
2021 · E. Lombardo, Lena Minibek, et al. · Virtual Community of Pathological Anatomy (University of Castilla La Mancha)
Clinical development of 2NME-based oncology treatment regimens
2011 · C.L. Jones, G. Lieberman, et al. · Contemporary Clinical Trials
2597
2006 · R. Kohl, R.S. Swann, et al. · International Journal of Radiation Oncology*Biology*Physics
207 Results of phase I clinical trials of adenoviral interferon-β gene therapy for malignant mesothelioma and malignant pleural effusions
2006 · D.H. Sterman, A. Recio, et al. · Lung Cancer
P19. Malignant pleural mesothelioma: evaluation with 18F-FDG PET
2003 · N. K. Gupta, P. Bhargava, et al. · Nuclear Medicine Communications
Neoadjuvant therapy for marginally resectable (clinical N2), non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
2000 · R W Byhardt, W T Sause, et al. · PubMed
182 Chemoradiation with or without surgery for stage IIIA non-small cell lung carcinoma (NSCLC): A comparison of survival and patterns of failure
1999 · M. Machtay, J.H. Lee, et al. · International Journal of Radiation Oncology*Biology*Physics
Safety of intrapleural adenoviral gene therapy: Prelude to clinical trial for malignant mesothelioma
1996 · D. Sterman, J. Kucharczuk, et al. · Lung Cancer
Adenovirus-mediated gene therapy for malignant mesothelioma: A comparison of immunosuppressed, immunodeficient and immunocompetent tumor models
1996 · A.A. Elshami, J.C. Kucharczuk, et al. · Lung Cancer
The expression of WT1 in malignant mesothelioma and its utility in the differential diagnosis of pleural-based lesions
1996 · K. Amin, A.M. Mooney, et al. · Lung Cancer
Works count: 23
Citation count: 353
H-index: 5
I10-index: 4
Year
Topic
Type